Sana Biotechnology
Seattle, US · 8 known investors
Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
BiotechHealthtechMedical Devices
Founders & leadership
SH
Steve HarrPresident and Chief Executive Officer
Investors · 8
American Family VenturesBoston · $250K – $10M
ARCH Venture PartnersChicago · $50K – $250M
F-Prime Capital PartnersCambridge · $3M – $10M
Flagship PioneeringCambridge · $500K – $10Mvia Geoffrey von Maltzahn · board
Innovating CapitalNew York · $10K – $3M
JDRF T1D FundBoston
Manta Ray VenturesLondon
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Founder mafia
3 people who came through Sana Biotechnology went on to found or lead other companies.
Competitors · 4
by search overlapRobinhood66 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha65 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Day One Biopharmaceuticals63 shared keywordsDay One Biopharmaceuticals is an oncology drug developer that pursues a "search and development" strategy to bring targeted cancer medicines to patients of all ages, with a focus on pediatric low-grade glioma (pLGG). The company is part of Servier.
Simply Wall St58 shared keywordsSimply Wall St is a stock analysis platform that provides portfolio insights, stock discovery tools, and market alerts for individual investors. The service offers institutional-grade financial data visualization and analysis across 120,000 global stocks.
Companies competing with Sana Biotechnology for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Sana Biotechnology (SANA) Is Up 18.1% After Removal From Key Russell Value Indexes - What's Changed - Simply Wall St Newssimplywall.st · Jul 2026Frequently asked questions
- What does Sana Biotechnology do?
- Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
- Who are Sana Biotechnology's investors?
- Sana Biotechnology's investors include American Family Ventures, ARCH Venture Partners, F-Prime Capital Partners, Flagship Pioneering, Innovating Capital, JDRF T1D Fund, Manta Ray Ventures, OUP (Osage University Partners).
- Where is Sana Biotechnology headquartered?
- Sana Biotechnology is headquartered in Seattle, US.